top of page
All Posts
How Long Does Patient Recruitment Take in the UK? Realistic Timelines by Study Type
For most UK studies, patient recruitment takes weeks to many months, not a fixed number of days. A small, well-defined Phase I study may identify and enrol volunteers quickly, while a rare-disease or highly selective Phase III study can take considerably longer. The practical answer depends on the number of participants required, how many sites are active, the eligibility criteria, and whether potential participants can be identified through current clinical records. This dis
Guy hudson
Nov 129 min read
Narrow Eligibility Criteria: How They Slow Recruitment And How To Test Them Early
Narrow clinical trial eligibility criteria can make a study scientifically cleaner while making it much harder to recruit. Every additional age limit, treatment-history rule, laboratory threshold, comorbidity exclusion or geographic requirement reduces the number of people who can enter the funnel. The result may be a higher screen-failure rate, slower enrolment, weaker representation and more pressure to add sites after the protocol is already approved. The answer is not to
Guy hudson
Nov 129 min read
Pre-Screening Explained: What Happens Between Identifying A Patient And Enrolling Them
Clinical trial pre-screening is the early review that asks whether a person might be suitable for a study before the full, protocol-specific screening process begins. A potential participant may still decline contact, fail a formal eligibility check, need further information, or be deferred while a clinical question is clarified. The practical sequence is usually: define the study criteria, identify a possible match, review limited relevant information, contact the person thr
Guy hudson
Nov 1210 min read
Patient Retention: Keeping Participants Enrolled Once They're Recruited
Clinical trial participant retention is the work of supporting people to remain involved long enough to complete the study activities they agreed to, including follow-up assessments. It matters because missing outcome data can make results less precise or harder to interpret. Retention is not the same as persuading everyone to stay: participants remain free to stop treatment, change what they do, or withdraw in line with the study information and applicable requirements. Stro
Guy hudson
Nov 128 min read
What Makes TrialChoices One of the Largest Patient Recruitment Firms in Europe?
TrialChoices is one of the largest patient recruitment firms in Europe, giving research teams direct access to 5 million UK patients through its network of GP practices, with a further 9 million reachable through wider Primary Care Network (PCN) searches. But scale on its own is not what sets the model apart. It is the combination of size, live NHS records and a direct route to the GP that allows initial patient cohorts to be identified in hours and days rather than weeks and
Guy hudson
Nov 126 min read
How Charities Can Accelerate Research Into Rare and Underserved Conditions
For many people living with a rare or underserved condition, medical research represents hope. Hope for earlier diagnosis. Hope for better treatments. Hope for improved quality of life. Charities have long played a vital role in turning that hope into action. They raise awareness, fund research, support patients and families, and advocate for better healthcare. However, many charities are now discovering they can contribute in another equally important way: helping researcher
Guy hudson
Sep 144 min read
Oncology Trial Recruitment: How Real-Time GP Access Changes the Timeline
Cancer research continues to advance at an extraordinary pace. New therapies, personalised treatments, targeted medicines, and immunotherapies are creating more opportunities than ever before to improve patient outcomes. However, every oncology study depends on one critical factor before any meaningful results can be achieved: recruiting the right patients. Finding eligible participants for cancer trials is rarely straightforward. Many studies have highly specific eligibility
Guy hudson
Sep 144 min read
Recruiting for Rare Disease Trials: Why Volume and Reach Matter Most
Recruiting participants is one of the biggest challenges in any clinical trial. For rare disease studies, that challenge becomes even greater. Unlike common conditions, rare diseases affect relatively small numbers of people. Patients may be spread across the country, receive care from different healthcare providers, or spend years searching for an accurate diagnosis. Even when an effective study is ready to begin, identifying eligible participants can take far longer than ex
Guy hudson
Sep 144 min read
Patient Recruitment for Academic Trials: Why Speed Often Isn't the Priority (And Why It Should Be)
Academic clinical trials have helped shape modern medicine for decades. Universities, NHS Trusts, and research institutions continue to lead studies that improve treatments, influence clinical guidelines, and answer important healthcare questions. Yet despite the quality of the research itself, many academic trials face one persistent challenge: patient recruitment. Unlike commercial pharmaceutical studies, academic trials often work with tighter budgets, smaller teams, and l
Guy hudson
Sep 144 min read
Cardiovascular Trial Recruitment: Reaching the Right Patient Populations
Cardiovascular trials come with a unique challenge. The patient population is large, but finding the right participants is not always straightforward. Conditions like hypertension, heart disease, and stroke affect millions of people. Yet when strict eligibility criteria are applied, the pool becomes smaller and harder to access. That is why recruitment in cardiovascular trials is not just about scale. It is about precision. Why Cardiovascular Recruitment Is More Complex Than
Guy hudson
Jun 43 min read
Rare Disease Trials: How to Find and Recruit Hard-to-Reach Participants
Rare disease trials face one major challenge from the start. Finding the right patients. Unlike common conditions, rare diseases have small, scattered populations. Patients may be spread across regions, misdiagnosed, or not actively connected to research opportunities. This makes recruitment slower, more complex, and often unpredictable. Why Rare Disease Recruitment Is So Difficult The issue is not just low numbers. It is also about visibility and access. Patients with rare c
Guy hudson
Jun 43 min read
Device vs. Drug Trials: How Recruitment Strategy Differs
Not all clinical trials recruit the same way. Device trials and drug trials may share similar goals — testing safety and effectiveness — but the way patients are identified, approached, and enrolled can be very different. If recruitment strategy does not match the type of trial, delays are almost guaranteed. Why Recruitment Strategy Cannot Be One-Size-Fits-All It is easy to assume that recruitment is simply about finding eligible patients. But the type of study changes everyt
Guy hudson
Jun 44 min read
Why Your Clinical Trial Is Struggling to Recruit — and How to Fix It
Recruitment delays are one of the most common reasons clinical trials fall behind. You may have a strong protocol, experienced sites, and full funding. Yet enrolment still moves slowly. When that happens, most teams try to fix the problem later. But the truth is simple. Most recruitment issues are created early — before a single patient is contacted. Where Things Usually Go Wrong Slow recruitment rarely starts with patient outreach. It often comes from early assumptions about
Guy hudson
Jun 43 min read
How GP Practices Can Earn More by Partnering With Clinical Trial Recruitment Trials
GP practices are under constant pressure. From increasing patient demand to administrative workload and limited resources, it can be difficult to find new ways to generate income without adding strain to daily operations. One opportunity that is often overlooked is participation in clinical trial recruitment. By partnering with organisations like TrialChoices, GP practices can play an active role in medical research while also creating a new, sustainable revenue stream. Why C
Guy hudson
Apr 294 min read
Why Real-Time Access to UK Patient Data Is a Game Changer for Global Clinical Trials
Clinical trials are no longer limited by geography, but they are still limited by access. Global research teams can design multi-country studies, collaborate across borders, and scale faster than ever before. Yet one challenge remains constant: finding the right patients, at the right time, in the right locations. That is where real-time access to UK patient data changes everything. Instead of relying on outdated estimates or slow recruitment methods, research teams can make
Guy hudson
Apr 294 min read
The Hidden Cost of Slow Recruitment: How Trial Timelines Are Decided Before a Patient Is Even Contacted
Clinical trial delays rarely begin where people expect. Most teams assume recruitment problems start when patients are slow to respond, sites struggle to enrol, or outreach campaigns underperform. But in reality, many delays are already locked in long before the first patient is contacted. The biggest hidden cost in clinical research is not just slow recruitment. It is poor early visibility — not knowing how many suitable patients are actually accessible, where they are locat
Guy hudson
Apr 295 min read
Why Scale Matters in Clinical Trial Recruitment: What Access to 3.1 Million UK Patients Actually Means for Your Study
Clinical trial recruitment looks simple on paper. Define the criteria, identify the right patients, make contact, and move the study forward. In practice, it rarely works that neatly. One of the biggest reasons is scale. When a study depends on finding a very specific patient group within a limited time frame, access matters. That is why TrialChoices’ model stands out. The organisation positions itself around connecting global research with UK patients, with direct access to
Guy hudson
Apr 296 min read
How Clinical Trials Benefit GP Practices and Their Patients
Clinical trials play a crucial role in advancing healthcare, offering new insights into treatments, preventive measures, and innovative care approaches. For GP practices, involvement in clinical trials provides unique opportunities to improve patient care while staying at the forefront of medical innovation. Overview of Clinical Trials Clinical trials are structured studies designed to test new treatments, interventions, or healthcare approaches. While many people think of t
Guy hudson
Mar 276 min read
Accessing UK Patient Populations for Clinical Trials at Scale
Large-scale patient access is essential for conducting faster, more diverse, and more efficient clinical trials. In the UK, the combination of GP practices, research networks, and digital recruitment systems allows sponsors and primary care providers to reach eligible participants quickly while maintaining compliance and high-quality data. Accessing UK patient populations for clinical trials at scale ensures studies can meet enrollment targets, improve representation, and del
Guy hudson
Mar 276 min read
Step-by-Step: How GPs Can Start Referring Patients to Trials
Clinical trial referrals are a key part of advancing medical research and improving patient care. For GPs, understanding how to start referring patients to trials can have a major impact on healthcare outcomes. Step-by-step guidance ensures that GPs can confidently support research while providing new treatment opportunities to their patients. GP participation is critical because primary care providers are uniquely positioned to identify suitable patients, explain the trial p
Guy hudson
Mar 277 min read
bottom of page